Qvar
(Beclomethasone)PreclinicalSmall molecule
Chiesi Farmaceutici S.p.A.Beclomethasone is an inhaled or nasal corticosteroid used to prevent and treat asthma symptoms and reduce nasal inflammation from allergies or nasal polyps.[1] Qvar is currently being investigated across 4 indications[3], with its most advanced program in Preclinical.[1]
Qvar is one of 121 small molecule programs targeting Allergy. It is currently in Preclinical.
4
Indications
23
Total Trials
1
Active Trials
120
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
119 competitors in Chronic Obstructive Pulmonary Disease
#DrugCompanyPhaseTrials
1Lunsekimig
SanofiPhase 3
CM310
KKeymed Biosciences Co.Ltd
Phase 3
Sildenafil ODT
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 2
Astegolimab
RochePhase 3
Tozorakimab
AstraZenecaPhase 3
Avinza
HHikma Pharmaceuticals LLC
Phase 2
HSK39004
Haisco Pharmaceutical Group Co., Ltd.Phase 2
Qvar
Chiesi Farmaceutici S.p.A.Preclinical
RLS-0071
RReAlta Life Sciences, Inc.
Phase 2
Calciferol
Jazz PharmaceuticalsPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Asthma8 trials
Show 5 more trials
Treatment2 trials
Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Completed·—·Phase 2·NCT05970731·16 enrolled
Gene Expression2 trials
Wheezing2 trials
THL1 trial
Beclomethasone in Healthy Athletes
Unknown status·—·Phase 4·NCT05352191·30 enrolled
8 more indications
Vitiligo1 trial
Betamethasone Phonophoresis For Vitiligo
Recruiting·—·N/A·NCT07267273·60 enrolled
Dyspnea1 trial
Sore Throat1 trial
Chronic Graft Versus Host Disease1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Beclomethasone. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company